The report "Global Facial Injectables Market, By Product (Dermal Fillers and Anti-Wrinkle Injection), By Application (Wrinkle Reduction, Facelift, Lip Enhancement, and Other Applications), By End-User (Hospitals, Dermatology Centers, Beauty Clinics, and Others), and By Region - Global Forecast to 2029"
Facial injectables market is projected to grow from US$ 12.5 billion in 2020 to US$ 29.23 billion by 2030. Global facial injectables market is driven by increasing prevalence of various cosmetic skin problems which include deep lines, scars, and wrinkles. In addition, changing lifestyle, rising disposable income and rapid inclination towards non-invasive procedure for facial treatment is expected to augment growth of the global facial injectables market over the forecast period. Furthermore, increasing product launch and approval supports from regulatory bodies is expected to fuel growth of the global facial injectables market in the near future. Moreover, growing healthcare sector across the globe is expected to spur growth of the global facial injectables market in the near future.
Key Highlights:
· In 2018, Allergan Plc, a pharmaceutical company has announced plans to acquire Elastagen Pty Ltd, which is an Australia-based medical company. Further, the acquisition focuses on incorporating of elastagen’s clinical stage tropoelastin platform into its facial injectables portfolio.
Key Market Insights from the report:
The global facial injectables market accounted for US$ 12.5 billion in 2020 and is projected to register a moderate CAGR of 8.9% over the forecast period. The market report has been segmented on the basis of product, application, end-user, and region.
· By product, the dermal filler segment is expected to hold dominant position in the global market over the forecast period. This is owing to increasing use of hyaluronic acid as dermal filler or in cosmetic preparations. Further, hyaluronic acid has become an integral part of cosmetics due to its strong water retention properties and it has lower molecular weight which further facilitates deep penetration of the product in the epidermis. Besides it helps retain water in the cells, releases antioxidants, and delays the aging process.
· By application, the global facial injectables are classified into wrinkle reduction, facelift, lip enhancement, and other applications.
· By end-user, the global facial injectables market is categorized into hospitals, dermatology centers, beauty clinics, and others. The beauty clinics segment is projected to significant growth in the global market over the forecast period. This is owing to facial injectables treatment primarily provides by beauty clinics across the globe.
· By region, North America is expected to accounts for major revenue share as compared to others region over the forecast period. This is attributed to increasing aging population and higher demand for non-invasive aesthetic procedures in the countries of the region.
Before purchasing this report, request a sample or make an inquiry by clicking the following link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/37
The prominent player operating in the global facial injectables market includes Allergan plc, Galderma S.A., Bioform Medical, Inc., Bausch Health Companies Inc. (Valeant Pharmaceuticals), Medicis Aesthetics Holdings, Inc., Elastagen Pty Ltd, Merz Pharma GmbH, and AG and Co. KGaA.
